Skip to content

The Role of Melatonin in the Effective Attainment of Sleep Electroencephalograms (EEG) in Children

The Role of Melatonin in the Effective Attainment of Sleep Electroencephalograms (EEG) in Children

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02195661
Enrollment
194
Registered
2014-07-21
Start date
2014-04-30
Completion date
2017-10-31
Last updated
2017-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Electroencephalogram, Children, Sedation

Keywords

Epilepsy, Electroencephalogram, children, sedation

Brief summary

This study aims to determine the safety and effectiveness of oral melatonin as natural inducer of sleep to acquire useful EEGs in South African children following its introduction as the main agent used in the Neurophysiology department at Red Cross Children's Hospital. This is an observational retrospective study.

Interventions

DIETARY_SUPPLEMENTMelatonin

Sponsors

University of Cape Town
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 13 Years
Healthy volunteers
No

Inclusion criteria

* All children who were referred to the neurophysiology department who were either unable to keep still for their EEG, or required a sleep EEG as part of their epilepsy work-up and whose caregivers agreed to the administering of sedation with melatonin.

Exclusion criteria

* Those children undergoing prolonged EEG monitoring (telemetry) or within 24 hours of status epilepticus (prolonged or cluster of seizures). * Those children are not sedated as natural sleep is always attained with the prolonged monitoring studies, and for those with status epilepticus, there is usually evidence on the EEG of alteration secondary to the effects of status, and the medications administered to control the presenting event. * Any child deemed to unwell to undergo a non-emergency procedure. * Any child already receiving anticoagulant medications. * Any caregiver who deferred sedation for their child was also excluded from the study and in the unit the procedure attempted without sedation.

Design outcomes

Primary

MeasureTime frameDescription
Efficacy of melatonin to induce sleep for EEG studies6 monthsSuccessful attainment of EEG (in comparison to the unit's previous success rate)(Definition: successful attainment of EEG = completed sleep EEG, without excessive artefact enabling an comprehensive report to be generated in a child who undergoes the procedure without evidence of adverse drug reactions)

Secondary

MeasureTime frameDescription
Breakdown data from the successful EEGs -6 monthsYield in terms of EEG abnormalities - number of abnormal studies, number of studies yielding outcomes which will alter patient management

Other

MeasureTime frameDescription
Comparison of EEGs performed under melatonin sedation compared to previous unit protocol6 monthsTo compare the EEG recordings in comparison to a historical group of age matched recordings sedated with chloral and to establish if the outcomes achieved are in line with the previous unit practice.

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026